Ultra-Potent Brightening Serum

Manufacturer
Velocity Production and Packaging | CoValence | CoValence Laboratories
Effective date
2020-12-09
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-01 23:02:47

Label at a glance#

ProductUltra-Potent Brightening Serum
Active ingredientHYDROQUINONE
Label structure9 sections

Indications and uses

USES: For the gradual fading of hyperpigmentation spots

Dosage and administration

DIRECTIONS: If no improvement is seen after 3 months of treatment, use of this product should be discontinued. Lightning effect of this product may not be noticable when used on very dark skin. Children under 12 years of age: do not use unless directed by a doctor. Sun exposure should be limited by using a sunscreen agent, or protective clothing to cover bleached skin when using and after using this product in ord...

Label contents#

Full prescribing information#

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

ACTIVE INGREDIENT(S):

Hydroquinone........... 2%

Purpose

OTC - PURPOSE SECTION

PURPOSE:

Skin Lightener

Uses

INDICATIONS & USAGE SECTION

USES:

For the gradual fading of hyperpigmentation spots

Warnings

WARNINGS SECTION

WARNINGS:

When Using

OTC - WHEN USING SECTION

When uisng this product avoid contact with eyes. Some users of this product may experience a mild skin irritation.

Stop Use

OTC - STOP USE SECTION

Stop use and ask a doctor if skin irritation becomes severe.

Keep out

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Sun Alert

WARNINGS SECTION

SUN ALERT:

The Alpha and Beta Hydroxy Acids (AHA/BHA) in this product may increase sun sensitivity.

Wear sunscreen or protective clothing during use to protect against sunburn and for a week afterwards. Continue sun protection after the lightening regimen to avoid UV-induced pigmentations.

Dosage & Administration

DOSAGE & ADMINISTRATION SECTION

Adults: apply a small amount as a thin layer on the affected area once or twice daily, or use as directed by a doctor. Do not use on or around the eye area.

Directions

INSTRUCTIONS FOR USE SECTION

DIRECTIONS:

  • If no improvement is seen after 3 months of treatment, use of this product should be discontinued. Lightning effect of this product may not be noticable when used on very dark skin.
  • Children under 12 years of age: do not use unless directed by a doctor.
  • Sun exposure should be limited by using a sunscreen agent, or protective clothing to cover bleached skin when using and after using this product in order to prevent darkening from reoccuring.

Inactive ingredients

INACTIVE INGREDIENT SECTION

INACTIVE INGREDIENTS:

Propylene Glycol, Alcohol Denat., Azelaic Acid, Aqua (Water), Hamamelis Virginiana (Witch Hazel) Water, Lactic Acid (L), Kojic Acid, Salicylic Acid, Alcohol, Ascorbic Acid (L), Hydroxypropyl Methylcellulose, Sodium Hydroxide

Questions or comments?

OTC - QUESTIONS SECTION

Questions or comments?

Admire My Skin, 340 Royal Poinciana Way #317-356, Palm Beach FL 33480

www.admiremyskin.com

Principal display panel and carton images

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal display panel

Container labelContainer label

First accordion label, beneath the principal display panel

First accordion labelFirst accordion label

Second accordion label, beneath the principal display panel

Second accordion labelSecond accordion label

Outer carton

BoxBox

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72591-483272591-4832-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 12 matching rows.

Source Document#

Source XML · Source PDF

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
d30c873a-524e-36e8-e053-2a95a90a5f12777fceed-0028-5973-e053-2991aa0ac5e72021-12-13WarningsExact identifier
spl set id: 777fceed-0028-5973-e053-2991aa0ac5e7

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.